Related Experiment Video

Updated: Apr 7, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K

MST4 as a key driver of osteoclast activation in osteoporosis

Bin Zhang1, Jiangjiang Zhang2, Xuqiang Liu1

  • 1Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.

Journal of Pharmaceutical Analysis
|April 6, 2026
PubMed

Insights

Mammalian Sterile 20-like kinase 4 (MST4) is elevated in osteoporosis patients and drives osteoclast activity. Targeting MST4 may offer a new therapeutic strategy for preventing bone loss.

Area of Science:

  • Molecular biology
  • Cell biology
  • Bone biology

Background:

  • Osteoporosis is a bone disease characterized by excessive bone resorption due to heightened osteoclast activity.
  • The precise molecular mechanisms underlying osteoporosis remain incompletely understood.
  • Mammalian Sterile 20-like kinase 4 (MST4) is a kinase implicated in cellular signaling pathways.

Purpose of the Study:

  • To investigate the role of MST4 in osteoclast differentiation and function.
  • To explore MST4 as a potential therapeutic target for osteoporosis.

Main Methods:

  • Analysis of MST4 expression in blood samples from osteoporosis patients and healthy controls.
  • In vitro studies using stem cell-derived osteoclast models with MST4 knockdown and overexpression.
  • In vivo studies using ovariectomized (OVX) mouse models.
  • Investigation of the molecular mechanism involving MST4 and TRAF6.

Main Results:

  • MST4 expression was significantly increased in osteoporosis patients and negatively correlated with bone mineral density (BMD).
  • MST4 knockdown reduced osteoclast differentiation and bone resorption, while overexpression enhanced these processes.
  • MST4 promotes osteoclast activation by phosphorylating and enhancing TRAF6 autoubiquitination.

Conclusions:

  • MST4 is a key regulator of osteoclast-mediated bone resorption in osteoporosis.
  • The MST4-TRAF6 signaling axis represents a potential novel therapeutic target for osteoporosis treatment to prevent bone loss.
Keywords:
AutoubiquitinationMST4Osteoclast differentiationOsteoporosisPhosphorylationTRAF6

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.9K
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.5K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.1K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
8.7K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.0K